Decreased Phosphorylated Protein Kinase B (Akt) in Individuals with Autism Associated with High Epidermal Growth Factor Receptor (EGFR) and Low Gamma-Aminobutyric Acid (GABA)
Open Access
- 1 January 2015
- journal article
- Published by SAGE Publications in Biomarker Insights
- Vol. 10, BMI.S21946-94
Abstract
Dysregulation of the PI3K/AKT/ mammalian target of rapamycin (mTOR) pathway could contribute to the pathogenesis of autism spectrum disorders. In this study, phosphorylated Akt concentration was measured in 37 autistic children and 12, gender and age similar neurotypical, controls using an enzyme-linked immunosorbent assay. Akt levels were compared to biomarkers known to be associated with epidermal growth factor receptor (EGFR) and c-Met (hepatocyte growth factor (HGF) receptor) pathways and severity levels of 19 autism-related symptoms. We found phosphorylated Akt levels significantly lower in autistic children and low Akt levels correlated with high EGFR and HGF and low gamma-aminobutyric acid, but not other biomarkers. Low Akt levels also correlated significantly with increased severity of receptive language, conversational language, hypotonia, rocking and pacing, and stimming, These results suggest a relationship between decreased phosphorylated Akt and selected symptom severity in autistic children and support the suggestion that the AKT pathways may be associated with the etiology of autism.Keywords
This publication has 56 references indexed in Scilit:
- EGFR Inhibitor Erlotinib Delays Disease Progression but Does Not Extend Survival in the SOD1 Mouse Model of ALSPLOS ONE, 2013
- Decreased Epidermal Growth Factor (EGF) Associated with HMGB1 and Increased Hyperactivity in Children with AutismBiomarker Insights, 2013
- Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcomeBrain, Behavior, and Immunity, 2011
- The autism risk genes MET and PLAUR differentially impact cortical developmentAutism Research, 2010
- Unnatural Polyketide Analogues Selectively Target the HER Signaling Pathway in Human Breast Cancer CellsChemBioChem, 2010
- Hepatocyte growth factor (HGF) modulates GABAergic inhibition and seizure susceptibilityExperimental Neurology, 2010
- Differential monocyte responses to TLR ligands in children with autism spectrum disordersBrain, Behavior, and Immunity, 2010
- Elevated immune response in the brain of autistic patientsJournal of Neuroimmunology, 2009
- Reversal of learning deficits in a Tsc2+/− mouse model of tuberous sclerosisNature Medicine, 2008
- A comprehensive pathway map of epidermal growth factor receptor signalingMolecular Systems Biology, 2005